KALA BIO Inc. (NASDAQ: KALA)
$7.80
-0.0200 ( -0.26% ) 15.3K
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
Market Data
Open
$7.80
Previous close
$7.82
Volume
15.3K
Market cap
$33.09M
Day range
$7.42 - $7.69
52 week range
$4.21 - $15.94
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 1 | Jun 28, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |
8-k | 8K-related | 21 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
8-k | 8K-related | 13 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |